Zobrazeno 1 - 10
of 541
pro vyhledávání: '"Haddock Michael G"'
Autor:
Hallemeier, Christopher L., Merrell, Kenneth W., Neben-Wittich, Michelle A., Jethwa, Krishan R., Yoon, Harry H., Pitot, Henry C., Blackmon, Shanda, Shen, K. Robert, Tryggestad, Erik J., Giffey, Broc, Kazemba, Bret D., Viehman, Jason K., Harmsen, William S., Haddock, Michael G.
Publikováno v:
In Advances in Radiation Oncology August 2024 9(8)
Autor:
Abdou, Maya, Bogan, Aaron W., Thangaiah, Judith Jebastin, Grover, Autumn C., Ahmed, Safia K., Houdek, Matthew T., Haddock, Michael G., Pyfferoen, Brittany A., Petersen, Ivy A.
Publikováno v:
In Advances in Radiation Oncology June 2024 9(6)
Autor:
Ahmed, Safia K., Petersen, Ivy A., Grams, Michael P., Finley, Randi R., Haddock, Michael G., Owen, Dawn
Publikováno v:
In Advances in Radiation Oncology March 2024 9(3)
Autor:
Foote Robert L, Stafford Scott L, Petersen Ivy A, Pulido Jose S, Clarke Michelle J, Schild Steven E, Garces Yolanda I, Olivier Kenneth R, Miller Robert C, Haddock Michael G, Yan Elizabeth, Laack Nadia N, Arndt Carola A S, Buskirk Steven J, Miller Vickie L, Brent Christopher R, Kruse Jon J, Ezzell Gary A, Herman Michael G, Gunderson Leonard L, Erlichman Charles, Diasio Robert B
Publikováno v:
Radiation Oncology, Vol 7, Iss 1, p 174 (2012)
Abstract Over the past 20 years, several proton beam treatment programs have been implemented throughout the United States. Increasingly, the number of new programs under development is growing. Proton beam therapy has the potential for improving tum
Externí odkaz:
https://doaj.org/article/03bda32e844641a88347c04d11d1c38f
Publikováno v:
Radiation Oncology, Vol 7, Iss 1, p 67 (2012)
Abstract Background To report single-institutional clinical outcomes and toxicity with SBRT for cholangiocarcinoma. Methods From March 2009 to July 2011, 10 patients with 12 unresectable primary (n = 6) or recurrent (n = 6) cholangiocarcinoma lesions
Externí odkaz:
https://doaj.org/article/ca6791c2d91a410499adb7ef6dff0673
Publikováno v:
Radiation Oncology, Vol 6, Iss 1, p 134 (2011)
Abstract Background We aimed to assess outcomes of patients with anal cancer who underwent intensity-modulated radiotherapy (IMRT) and received less than 1.80 Gy/day. Methods We retrospectively reviewed our experience using a low fractional dose (< 1
Externí odkaz:
https://doaj.org/article/e1b5b1144ba342e69d959e0b97634245
Autor:
Zhou Jessica, Hruban Ralph H, Laheru Dan, Pawlik Timothy M, Bhatia Sumita, Hsu Charles C, Miller Robert C, Narang Amol K, Winter Jordan M, Haddock Michael G, Donohue John H, Schulick Richard D, Wolfgang Christopher L, Cameron John L, Herman Joseph M
Publikováno v:
Radiation Oncology, Vol 6, Iss 1, p 126 (2011)
Abstract Background The role of adjuvant chemoradiation therapy for ampullary carcinoma is unknown. Previous literature suggests that certain populations with high risk factors for recurrence may benefit from adjuvant chemoradiation. We combined the
Externí odkaz:
https://doaj.org/article/3250e8e367654e8d98f5d85f25f765cc
Autor:
Grams, Michael P., Deufel, Christopher L., Kavanaugh, James A., Corbin, Kimberly S., Ahmed, Safia K., Haddock, Michael G., Lester, Scott C., Ma, Daniel J., Petersen, Ivy A., Finley, Randi R., Lang, Karen G., Spreiter, Sheri S., Park, Sean S., Owen, Dawn
Publikováno v:
In Physica Medica July 2023 111
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Grams, Michael P., Tseung, Hok Seum Wan Chan, Ito, Shima, Zhang, Yan, Owen, Dawn, Park, Sean S., Ahmed, Safia K., Petersen, Ivy A., Haddock, Michael G., Harmsen, William S., Ma, Daniel J.
Publikováno v:
In Practical Radiation Oncology September-October 2022 12(5):e442-e452